期刊文献+

甘精胰岛素联合阿卡波糖与预混胰岛素治疗初发2型糖尿病的疗效和安全性比较 被引量:6

下载PDF
导出
摘要 【目的】比较甘精胰岛素联合阿卡波糖与预混胰岛素治疗新诊断的2型糖尿病患者的疗效和低血糖的风险。【方法】70例新诊断的2型糖尿病患者随机分为甘精胰岛素组(简称甘精组)和预混胰岛素组(诺和灵30R,简称预混组),每组各35例。甘精组每晚9时注射甘精胰岛素一次,三餐前口服阿卡波糖(拜糖平);预混组每日早晚餐前分别注射诺和灵30R预混胰岛素,共治疗16周,观察血糖控制和低血糖发生情况。【结果】治疗后两组的FBG和餐后血糖都明显下降,但甘精组的下降幅度明显大于预混组,差异有显著性(P<0.01);到达终点时预混组剂量明显大于甘精组,差异有显著性(P<0.05);甘精组低血糖事件明显少于预混组(甘精组5例,预混组16例,χ2=4.285,P<0.05)。【结论】初发2型糖尿病患者采用每日注射一次甘精胰岛素加口服阿卡波糖或每日2次注射预混胰岛素治疗,均能达到明显降糖效果。甘精胰岛素与预混胰岛素相比降低FBG的效果更好;低血糖的发生率低;胰岛素的用量少;每日一次皮下注射更方便,依从性更好。
作者 梁力晖
机构地区 湖南省人民医院
出处 《医学临床研究》 CAS 2007年第6期976-978,共3页 Journal of Clinical Research
  • 相关文献

参考文献8

  • 1Harris MI,Eastman RC,Cowie CC,et al.Racial and ethnic differences in glycemic control in adults with type 2 diabetes[J].Diabetes Care,1999,22:403-408. 被引量:1
  • 2Stratton IM,Adler AZ,Ncil HAW,et al.Association of glycemia with macrovascular and microvascular complications of type 2 diabetes;prospective observational study(UKPDS35)[J].BMJ,2000,321(12):405-412. 被引量:1
  • 3Klcin R,Klcin BE,Moss SE.Relation of glycemic control to diabetic microvascular complication in diabetes mellitus[J].Ann Intern Med,1996,124(1Pt2):90-96. 被引量:1
  • 4UKPDS study Group.Overview of six years therapy of type 2 diabetes a progressive disease(UKPDS16)[J].Diabetes Care,1995,44(11):1249-1258. 被引量:1
  • 5Turner RC,Cull CA,Frighiv,et al.Glycemic control with diet,sulfonylurea,metformin,or insulin in patients with type 2 diabetes mellitus:progressive requirement for multiple,therapies(UKPDS49)UK prospective diabetes study(UKPDS)Group[J].JAMA,1999,281(21):2005-2012. 被引量:1
  • 6卜石,邢小燕,王娜,赵文惠,杨文英.长效胰岛素联合口服降糖药治疗2型糖尿病的疗效与安全性[J].中国循证医学杂志,2004,4(7):464-467. 被引量:157
  • 7HOE 901/3002 Study Group.Less nocturnal hypoglycemia and better post dinner glucose control with bedtime insulin glargine compared with bedtime NPN insulin during insulin combination therapy in type 2 diabetes[J].Diabetes Care,2000,23(8):1130-1136. 被引量:1
  • 8Monnire L,Lapinsbi H,Coletle C,et al.Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients:variations with increasing lecels of HhAlc[J].Diabetes Care,2003,26(3):881-885. 被引量:1

二级参考文献8

  • 1Riddle MC,Rosenstock J,Gerich J.Insulin Glargine 4002 Study Investigators.The treat-to-target trial:randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients[J].Diabetes Care,2003; 26(11):3 080-3 086. 被引量:1
  • 2HOE 901/3002 Study Group.Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes[J].Diabetes Care,2000; 23(8):1 130-1 136 被引量:1
  • 3UKPDS Study Group.Stratton IM,Adler AI,Neil HAW,Matthews DR,Manley SE,Cull CA,Hadden D,Turner RC,Holman RR.Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes:prospective observational study (UKPDS 35) [J].BMJ,20 被引量:1
  • 4Wright A,Burden ACF,Paisey RB.Sulfonylurea Inadequacy:Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)[J].Diabetes Care,2002; 25(2):330-336 被引量:1
  • 5Turner RC,Cull CA,Frighi V,Holman RR.Glycemic control with diet,sulfonylurea,metformin,or insulin in patients with type 2 diabetes mellitus:progressive requirement for multiple therapies (UKPDS 49).UK Prospective Diabetes Study (UKPDS) Group[J].JAMA,1999; 被引量:1
  • 6UKPDS Study Group.Klein R,Klein BE,Moss SE.Relation of glycemic control to diabetic microvascular complications indiabetes mellitus[J].Ann Intern Med,1996;124(1 Pt 2):90-96 被引量:1
  • 7UKPDS Study Group.Overview of six years' therapy of type 2 diabetes-a progressive disease (UKPDS 16)[J].Diabetes Care,1995; 44(11):1 249-1 258 被引量:1
  • 8Matthaei S.Endocrine review[M],21(6):585-618 被引量:1

共引文献156

同被引文献38

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部